Alcanza Clinical Research

We are proud to announce Casey Orvin as our new Chief Commercial Officer. With Casey's proven track record in clinical research, he will drive growth, innovation, and strategic partnerships. We are looking forward to achieving new heights together!   Learn more about Casey joining the Alcanza team here: https://lnkd.in/edYguEMy

We're proud to announce that Dori Sarkis and Pamela Whitcomb will be representing Alcanza Clinical Research at the Alzheimer's Association International Conference (AAIC) this year! If you're interested in networking and learning more about our work in the Alzheimer's space, we'd love to connect. Please email Dori at [email protected] to set up a meeting. See you at AAIC!

Happy Independence Day from Alcanza Clinical Research! Today, we celebrate the spirit of freedom and unity. As we honor this special day, we remain committed to advancing medical research for a healthier future. Wishing everyone a safe and joyful July 4th!

June is Alzheimer's and Brain Awareness Month, and at Alcanza Clinical Research, we're dedicated to making a difference. Across our multiple sites, we're actively conducting groundbreaking studies to advance Alzheimer's research. Together, let's raise awareness, support those affected, and strive for a brighter future. Join us in making an impact today! 

On World Vitiligo Day, Alcanza Clinical Research stands in solidarity with those affected by vitiligo. We are committed to raising awareness and supporting research to better understand and treat this condition. Together, we can make a difference!

Today, Alcanza Clinical Research joins the nation in honoring Juneteenth, a pivotal day in American history that celebrates the end of slavery in the United States. We recognize this day's profound significance and its enduring impact on the African American community. As we commemorate Juneteenth, we remain committed to fostering diversity, equity, and inclusion in all that we do. Let's reflect, educate, and unite to build a better future.

Join us at the DIA 2024 Global Annual Meeting in San Diego to explore the future of inclusive clinical trials! Our CEO, Carlos E. Orantes, will share insights as a panelist on two key sessions. In the session "From Intention to Action: Building Diversity, Equity, and Inclusion Initiatives to Create a Culture of Belonging," he will discuss actionable strategies to foster an inclusive and diverse environment within clinical trials. Additionally, Carlos will be a panelist for "Strategies to Make Your Clinical Trials More Inclusive for Patients with Disabilities," offering practical guidance to ensure accessibility and equity for all participants. Both panels promise invaluable insights—don't miss out! #DIA #DIA2024

On this #MASHday, did you know that MASH (Metabolic dysfunction- associated steatohepatitis) replaces NASH (non-alcoholic steatohepatitis). It’s not just semantics; its progress! The recent name change reflects a major shift in understanding and prioritizing liver health. Join all of us at Alcanza Clinical Research and spread the word while empowering patients to take charge of their liver wellness.

At Alcanza Clinical Research, celebrating Pride Month is just one part of our ongoing commitment to diversity, equality, and inclusion. We believe in embracing and supporting the LGBTQIA community not just in June, but every day of the year.   Our core values ensure that every voice is heard and respected, fostering a welcoming environment for all. We are committed to conducting research that reflects the diversity of the communities we serve, including those within the LGBTQIA community. By ensuring inclusivity in our clinical trials, we strive to develop treatments that meet the needs of all individuals, regardless of gender identity or sexual orientation.   Join us in our continuous effort to build a world where everyone is valued for who they are.

Starting the week off on a high note, Alcanza Clinical Research is thrilled to announce our latest milestone: the acquisition of North Georgia Clinical Research (NGCR), headquartered in Woodstock, Georgia. This strategic move underscores our unwavering commitment to advancing clinical research. By merging our strengths, we bolster our capacity to drive groundbreaking treatments and extend our influence across Georgia and beyond.    Learn more about our acquisition here: https://lnkd.in/eT4i7UZC